Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Renren received a non-binding preliminary 'going private' offer from top executives at $4.20 per share in cash for each American depositary share.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Joseph Chen and Chen Ji are the CEOs of Renren
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Lars Minor on Newbury Pharmaceuticals’ Vision Ahead of IPO Launch | Lars Minor, CEO , Polymetals Resources Ltd.
00:10:00
Founding the Coret Task Force on K-12 Education: A Tribute to Tad Toby's Vision and Legacy|Tad Taube
00:10:00
BC Announces New Mining Jobs Task Force to Boost Industry and Support Electrification
00:10:00
The Realities of Retirement: Planning for Satisfaction
00:10:00
Planning for College: Patti Hughes on Discussing Student Loans with Your Child | Patti Hughe, Principal , Lake Life Wealth Advisory Group LLC.
00:10:00
"1970s Market Déjà Vu - A Dialogue with Jim Rogers " | Ronald Chan, Chartwell Capital Limited
00:10:00
Amex Exploration (TSXV-AMX; OTCQX-AMXEF) has seen a 50%+ move higher in its share price from its Fall, 2023 bottom: a looming resource estimate that will quite possibly establish|VICTOR CANTORE,CEO,Amex Exploration (IE)
00:10:00
The Owner’s Mentality: Insights from Greg Padilla, Portfolio Manager at Aristotle Capital
00:10:00
DCM: David focuses on consumer, fintech, and digital health.|David Cheng,Principal, DCM
00:10:00
Evolution of Financial Services: A Journey Through Franklin Templeton's Vision and Innovation | Jenny Johnsons, Chief Executive Officer , Franklin Templeton .
00:10:00
Mazagon Dock Shrugs Off Share Price Turbulence: MD Sanjeev Singhal Assures Growth Despite Brokerage Downgrades | MD Sanjeev Singhal, Chairman , Mazagon Dock Shipbuilders Ltd.
00:10:00
John Devaney, founder and CEO of United Capital Markets, appears on 'Squawk' to discuss market insights.